Site icon almostadoctor

Chlamydia

Introduction

Chlamydia Trachomatis (CT) is the most common bacterial STI. It is most common in those <30, and is often asymptomatic.

It is simple to test for and to treat. Previous infection does not give immunity and re-infection can occur.

Like gonorrhoea, chlamydia can also be spread vertically, and can result in aconjunctivitis in the neonate. However, unlike gonorrhoea, the conjunctivitis is not a medical emergency, and will noly very rarely result in blindness.

Epidemiology

Clinical features

Men

Women

Neonates

Other

Pathology

Chlamydia trachomatis is an intracellular bacteria. In many ways, its pathology is similar to that of a virus. It has a very short life-cycle. It will enter the epithelial cell, and form a reticulate body. This rapidly divides, creating hundreds of elimentary bodies. The host cell will die and release the elementary bodies, which are then able to infect more epithelial cells.
Chlamydae Life Cycle

Complications

Men

Women

Investigations

Diagnosis is difficult as cell culture is difficult and expensive. Instead, indirect testing techniques are used. ELISA testing is the old method, and was unreliable. Newer methods include PCR (polymerase chain reaction) and LCR (ligase chain reaction). These methods amplify DNA constituents – to replicate fragments of DNA – which can then be identified as being chlamydial in origin (or not).

Typically gonorrhoea is also tested for on the same sample

Indications

Sampling

Treatment

Tetracyclines or macrolides are most useful:
Treat immediately (prior to test result) if high index of suspicion, including treatment for partners.
Advice to patients

Follow-up

Advised at one week and again at 3 months.

Follow-up at one week to ensure:

Test of cure (TOC) is not routinely recommended, unless:

Perform repeat NAAT testing 4 weeks after finishing treatment if indicated

Re-infection is common. Some centres suggest re-testing all patients at 3 months to rule out re-infection.

Screening

References

Read more about our sources

Related Articles

Exit mobile version